Visual Feedback Therapy to Enhance Medication Adherence in Psychosis

Poupore, Eileen; Schepp, Karen G.

doi:10.1016/j.apnu.2005.02.008

Cited by 15 publications

(17 citation statements)

References 45 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A majority (68%) of articles reported high (n = 11; 27%), [17,19,24,27,31,33,37,40,41,43,44] moderate (n = 12; 29%), [11,[14][15][16]18,20,21,25,26,30,38,42] or significant (n = 5; 12%) [13,23,28,29,35] correlation between these types of measures.…”

Section: Correlation Between Self-report and Electronic Monitoringmentioning

confidence: 93%

“…Of the 41 actual articles, the disease states were as follows: HIV (n = 18; 43.9%), [11][12][13][14][15][16][17][18]20,26,28,31,33,[35][36][37]43,44] psychotic disorders (n = 4; 9.8%), [29,34,41,49] cardiovascular diseases (n = 3; 7.3%), [32,38,50] hypertension (n = 3; 7.3%), [23,24,27] transplant (n = 2; 4.9%) [21,30] and diabetes mellitus (n = 2; 4.9%). [19,46] The sample sizes ranged from 5 to 1021 (median = 61).…”

Section: Study Characteristicsmentioning

confidence: 99%

See 1 more Smart Citation

Concordance of Adherence Measurement Using Self-Reported Adherence Questionnaires and Medication Monitoring Devices

et al. 2010

View full text Add to dashboard Cite

The primary objective of this review was to identify and examine the literature on the association between medication adherence self-reported questionnaires (SRQs) and medication monitoring devices. The primary literature search was performed for 1980-2009 using PubMed, PubMed In Process and Non-Indexed, Ovid MEDLINE, Ovid MEDLINE In-Process, PsycINFO (EBSCO), CINAHL (EBSCO), Ovid HealthStar, EMBASE (Elsevier) and Cochrane Databases and using the following search terms: 'patient compliance', 'medication adherence', 'treatment compliance', 'drug monitoring', 'drug therapy', 'electronic', 'digital', 'computer', 'monitor', 'monitoring', 'drug', 'drugs', 'pharmaceutical preparations', 'compliance' and 'medications'. We identified studies that included SRQs and electronic monitoring devices to measure adherence and focused on the SRQs that were found to be moderately to highly correlated with the monitoring devices. Of the 1679 citations found via the primary search, 41 full-text articles were reviewed for correlation between monitoring devices and SRQs. A majority (68%) of articles reported high (27%), moderate (29%) or significant (12%) correlation between monitoring devices (37 using Medication Event Monitoring System [MEMS®] and four using other devices) and SRQs (11 identified and numerous other unnamed SRQs). The most commonly used SRQs were the Adult/Pediatric AIDS Clinical Trial Group (AACTG/PACTG; 24.4%, 10/41) followed by the 4-item Morisky (9.8%, 4/41), Brief Medication Questionnaire (9.8%, 4/41) and visual analogue scale (VAS; 7.3%, 3/41). Although study designs differed across the articles, SRQs appeared to report a higher rate of medication adherence (+14.9%) than monitoring devices. In conclusion, several medication adherence SRQs were validated using electronic monitoring devices. A majority of them showed high or moderate correlation with medication adherence measured using monitoring devices, and could be considered for measuring patient-reported adherence prospectively.

show abstract

Section: Correlation Between Self-report and Electronic Monitoringmentioning

confidence: 93%

Section: Study Characteristicsmentioning

confidence: 99%

Concordance of Adherence Measurement Using Self-Reported Adherence Questionnaires and Medication Monitoring Devices

et al. 2010

View full text Add to dashboard Cite

show abstract

“…It is generally agreed that "lack of insight" is a significant contributor to medication nonadherence. However, there is a great deal of variability in the research literature concerning the magnitude of this association, [15][16][17][18][19][20] and some studies have not found any association whatsoever. [21][22][23] While this is perhaps not surprising given differences in the setting, methods, and definitions of insight and adherence used in various studies, another possible explanation is that certain kinds of cognitive deficits may disrupt any association between attitude about the illness (insight) and behavioral outcomes that are influenced by such an attitude (medication adherence).…”

Section: Introductionmentioning

confidence: 91%

Why Do Patients with Schizophrenia Who Have Poor Insight Still Take Antipsychotics? Memory Deficits as Moderators Between Adherence Belief and Behavior

Staring

Gaag

Duivenvoorden

et al. 2011

Journal of Psychiatric Practice

View full text Add to dashboard Cite

While lack of insight is often predictive of antipsychotic nonadherence, some inconsistency in the literature remains unexplained. Verbal memory deficits may moderate the association between insight and adherence. Based on cross-sectional data, outpatients treated with antipsychotics for a psychotic disorder were divided into those with good (n=53) and poor (n=59) memory. Poor insight predicted nonadherence only among the subgroup with relatively good memory (r=0.43; P<0.01), but had no effect in the subgroup with worse memory (r=0.08; ns). Structural equation modelling revealed significant moderation (χ=4.72; df=1; P<0.05), which means that a significantly better model fit was found by allowing the analysis to differentiate between the two memory groups. Thus, poor insight was only associated with poor medication adherence among patients with relatively good memory. We speculate that memory deficits commonly associated with schizophrenia may partly explain why poor insight does not always lead to poor medication adherence.

show abstract

“…To minimize the loss of data, data were coded at the time of each meeting, every 2 weeks, without showing the subjects the chronology from the electronic monitoring device. From our previous study (Kozuki and Schepp, 2005), we found that, if multiple regimens were prescribed and taken by the patient, adherence rates were similar, and only one electronic monitoring device was used for each participant even if the participant was on more than one medication. Pill counts validated the results of the electronic monitoring and were used to detect possible deceptions.…”

Section: Adherence Measuresmentioning

confidence: 93%

“…This stored information was downloaded and presented to the subjects on a computer screen at each visual therapy session. From our previous study (Kozuki and Schepp, 2005) on the feasibility of using an electronic monitoring device with people with schizophrenia, we identified five behavioural patterns of pill-taking behaviours from the continuous adherence data of the 45 electronic monitoring device units utilized. Behavioural feedback was provided based on these five patterns: (i) skipping doses; (ii) complete cessation; (iii) complete irregularity; (iv) irregularities related to a more than once-a-day regimen; (v) drug holiday (Urquhart, 1997).…”

Section: Visual-feedback Therapy (Experimental Condition)mentioning

confidence: 99%

Visual-feedback therapy for antipsychotic medication adherence

Schepp

2006

International Clinical Psychopharmacology

Self Cite

View full text Add to dashboard Cite

This pilot study aimed to examine the effectiveness of visual-feedback therapy for individuals with psychotic disorders. Visual-feedback therapy combines structured psychodynamic therapy and visual feedback achieved via an electronic monitoring medication cap to increase insight about medication behaviours. Thirty subjects were randomly assigned either to visual feedback or to a supportive counselling group. Medication adherence was measured by both electronic monitoring and blood plasma drug concentration levels. The results showed that, at the end of the 3-month, intervention (bimonthly sessions), adherence rates of the visual-feedback group slightly increased, but declined during the course of the study for the supportive counselling control group (P=0.026).

show abstract

Visual Feedback Therapy to Enhance Medication Adherence in Psychosis

Cited by 15 publications

References 45 publications

Concordance of Adherence Measurement Using Self-Reported Adherence Questionnaires and Medication Monitoring Devices

Concordance of Adherence Measurement Using Self-Reported Adherence Questionnaires and Medication Monitoring Devices

Why Do Patients with Schizophrenia Who Have Poor Insight Still Take Antipsychotics? Memory Deficits as Moderators Between Adherence Belief and Behavior

Visual-feedback therapy for antipsychotic medication adherence

Contact Info

Product

Resources

About